Literature DB >> 15377737

A neuropsychological comparison of psychotic disorder following traumatic brain injury, traumatic brain injury without psychotic disorder, and schizophrenia.

Daryl Fujii1, Iqbal Ahmed, Earl Hishinuma.   

Abstract

Neuropsychological functioning in individuals with psychotic disorder following traumatic brain injury (PDFTBI), traumatic brain injury without psychosis (TBIWP), and schizophrenia were compared against each other and to the means of normal subjects. It was predicted that the PDFTBI group would be similar to the schizophrenic group in patterns of deficits, but milder in severity. Compared to scores from a normal sample, the PDFTBI group scored significantly lower in intelligence, vocabulary, verbal memory, and executive functioning, while the schizophrenic group scored significantly lower in intelligence, working memory, verbal memory, visual spatial abilities, and executive functioning. No differences were found between normal subjects and the TBIWP group. Implications of our findings for the conceptualization of psychotic disorders are discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15377737     DOI: 10.1176/jnp.16.3.306

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  2 in total

1.  Traumatic brain injury in individuals at clinical high risk for psychosis.

Authors:  Stephanie Deighton; Lisa Buchy; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel Mathalon; Jean Addington
Journal:  Schizophr Res       Date:  2016-05-07       Impact factor: 4.939

2.  Psychiatric disorders and traumatic brain injury.

Authors:  Marcelo Schwarzbold; Alexandre Diaz; Evandro Tostes Martins; Armanda Rufino; Lúcia Nazareth Amante; Maria Emília Thais; João Quevedo; Alexandre Hohl; Marcelo Neves Linhares; Roger Walz
Journal:  Neuropsychiatr Dis Treat       Date:  2008-08       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.